Latest Breaking News On - Arnaud del - Page 1 : comparemela.com

Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria

Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berlin
Germany
Washington
United-states
Paris
France-general
France
American
Felix-lauscher
Corentine-driancourt
Relationseva-schaefer-jansen
Naimish-patel

Press Release: Sanofi's Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors

Press Release: Sanofi's Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France
Brussels
Bruxelles-capitale
Belgium
Paris
France-general
California
United-states
Rachel-duan
Nicolas-obrist
Diane-souza
Relationseva-schaefer-jansen

Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Japan
Canada
United-kingdom
Paris
France-general
France
Great-britain
Astrazeneca-beyfortus
Relationseva-schaefer-jansen
Relationssandrine-guendoul
Nicolas-obrist

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Paris
France-general
France
American
Surya-bhatt
Relationssandrine-guendoul
Relationssharon-chen
Felix-lauscher
Nathalie-pham
Relationsvesna-tosic

Sanofi (SNY) announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.

Sanofi (SNY) announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
Felix-lauscher
Relationseva-schaefer-jansen
Nicolas-obrist
Nathalie-pham
Tarik-elgoutni
Relationssandrine-guendoul
Kristen-kelleher
Evan-berland
Corentine-driancourt
Sanofi-investor-relations-department